George Washington University Hospital, Washington, DC, USA.
Queen Elizabeth Hospital, Birmingham, UK.
Br J Haematol. 2020 Nov;191(4):612-616. doi: 10.1111/bjh.17151.
Bone marrow transplantation (BMT) has evolved over the last 60 years from a pioneering treatment fraught with unknown factors and complications to a widely practiced standard of care that has saved the lives of countless individuals with malignant and non-malignant conditions. Over this period, transplanters in the UK have made a significant international contribution to the field through cutting edge clinical and laboratory research. Today, stem cell transplantation in the UK continues to advance through rigorous and innovative clinical trials which focus on improving outcome by reducing transplant toxicity and the risk of disease relapse. In this review, we start with a personal view of the early years of BMT in the UK, document the many seminal accomplishments in the field of BMT which took place in the UK, and end with a look towards the future of BMT, in the UK and worldwide.
骨髓移植(BMT)在过去的 60 年中经历了从充满未知因素和并发症的开创性治疗到广泛应用的标准治疗的演变,为数以百万计患有恶性和非恶性疾病的患者挽救了生命。在此期间,英国的移植医生通过前沿的临床和实验室研究为该领域做出了重大的国际贡献。如今,英国的干细胞移植通过严格和创新的临床试验不断发展,这些临床试验通过降低移植毒性和疾病复发的风险来提高治疗效果。在这篇综述中,我们首先从个人角度回顾了英国早期的 BMT,记录了在英国发生的许多 BMT 领域的开创性成就,最后展望了英国和全球的 BMT 未来。